Automatic thresholding of infected blood images using granulometry and regional extrema

Author(s):  
C. Di Ruberto ◽  
A. Dempster ◽  
S. Khan ◽  
B. Jarra
1984 ◽  
Vol 16 (4) ◽  
pp. 411-412
Author(s):  
Gunnar Bjune ◽  
Tom Erik Ruud ◽  
Jan Eng

2016 ◽  
Vol 10 (1) ◽  
pp. 49-55 ◽  
Author(s):  
Aliyu Muhammad ◽  
Mohammed Ibrahim ◽  
Ochuko Erukainure ◽  
Nathan Habila ◽  
Aimola Idowu ◽  
...  

Author(s):  
Shawna Bellamy ◽  
Barry W Alto

Abstract Non-lethal predator-prey interactions during the immature stages can cause significant changes to mosquito life history traits and their ability to transmit pathogens as adults. Treatment manipulations using mosquitoes Aedes aegypti (L.) and Toxoryhnchites rutilus (Coquillett) were performed during the immature stages to explore the potential impacts of non-lethal interactions on adult susceptibility to infection, disseminated infection and saliva infection of Ae. aegypti following ingestion of Zika virus-infected blood. Treatments inducing density reduction resulted in reduced development time and survivorship to adulthood. However, effects of treatment did not alter infection, dissemination, or saliva infection. These observations indicate that, while non-lethal predation may impact some traits that influence population dynamics and transmission of pathogens, there were no direct effects on mosquito-arbovirus interactions.


Vaccines ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 279
Author(s):  
Juan José Tejada-Pérez ◽  
Juan José Vázquez-Vicente ◽  
María Renée Herrera-Burgos ◽  
Francisco Gabriel Martín-Martín ◽  
Tesifón Parrón-Carreño ◽  
...  

Hepatitis B (HBV) is a pathogen virus with transmission mechanisms that include contact with the infected blood or bodily fluids of the infected organism. Nowadays, healthcare workers are one of the most exposed groups to HBV. Conventionally, completing a vaccine series dosage with Engerix B® lowers this risk by providing workers with immunity to the virus. However, through the years, we have encountered nonresponsive health personnel to the Engerix B® vaccine; hence, the Occupational Health Service of Poniente Hospital studied the Fendrix® adjuvanted vaccine as an alternative vaccine to develop immunological responses in healthcare workers who do not respond to vaccination with Engerix B®. In our study, we employed a vaccination schedule with the Fendrix® vaccine, performing serology tests on the cases after the application of each dose. The results obtained showed humoral immunity in 92.3% of the cases, with a remarkable increase in antibody titer after the first doses. These encouraging results support the future inclusion of this vaccine as one possible alternative for the immunization to HBV for healthcare workers nonresponsive to Engerix B®.


Transfusion ◽  
1994 ◽  
Vol 34 (3) ◽  
pp. 198-201 ◽  
Author(s):  
V Massari ◽  
MH Elghouzzi ◽  
F Agis ◽  
C Rannou ◽  
E Gordien ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document